New Insights in the Genetics and Genomics of Adrenocortical Tumors and Pheochromocytomas
| New Insights in the Genetics and Genomics of Adrenocortical Tumors and Pheochromocytomas |
| Autore | Igaz Peter |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (272 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
adaptive metabolism
adenoma adrenal adrenal gland adrenalectomy adrenocortical adrenocortical carcinoma adrenocortical tumor aldosterone aldosterone producing adenoma aldosterone-producing adenoma ALT arterial stiffness artificial intelligence ATP2B3 ATRX bioinformatic clustering biomarker biomarker prediction cancer circulating conn adenoma driver mutations drug discovery endocrine tumor syndrome environment epidemiology epigenetics fatty acid metabolism ferroptosis genetic analysis genetic testing genetics germline H295 strains hereditary hereditary cancer hyperaldosteronism in silico analysis K416-F418delinsN mutation KCNJ5 somatic mutation machine learning malignancy metabolic reprogramming metabolomics metastatic microRNA mitochondrial complex II mitotane mortality mutations n/a neonatal screening neural network next generation sequencing Next Generation Sequencing non-coding RNA NOP10 paraganglioma paragangliomas phaeochromocytoma pheochromocytoma pheochromocytomas PPARα PPGL primary aldosteronism prognostic biomarker propensity score matching pulse wave velocity redox balance pathway RNAseq screening somatic surveillance susceptibility genes telomeres TERT therapy tissue TP53 R337H transcriptomics treatment tumor microenvironment tumor suppressor genes variants Vitamin C zebrafish β-oxidation |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557609003321 |
Igaz Peter
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Updates on Molecular Targeted Therapies for CNS Tumors
| Updates on Molecular Targeted Therapies for CNS Tumors |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2023 |
| Descrizione fisica | 1 online resource (368 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
A172
A2AAR antagonist adenosine adenosine receptors antigen processing and presentation antioxidant apoptosis ATRX bevacizumab biomarker blood-brain barrier brain metastasis brain tumor cancer metabolism cell cycle arrest central nervous system chemotherapy CNS disease CNS lymphoma CpG island diffuse midline gliomas DNMT EGFR ependymoma EPHB2 epidermal growth factor receptor ERK/MAPK pathway FGFR3 G-CIMP GBM germline mutation glioblastoma glioblastoma molecular classification glioma Group A Group B H3K27M histone acetylation IDH-mutant glioma immune evasion immune score immunotherapy intraparenchymal metastases intrathecal isotope labeling KIF11 leptomeningeal low grade glioma low-grade glioma LPS lung cancer lung carcinoma lung malignancy mass spectrometry meningitis MET metastatic disease Metformin methotrexate methylation methylomics methyltransferases MGMT molecular targets molecular therapy monoclonal antibodies MYCN myxopapillary n/a neoantigen neoplastic neurofibromatosis NF1 novel therapeutics novel therapies patient avatars PCNSL PDGFRA pediatric brain tumor PFA PFB PI3K/PTEN pathway plexiform neurofibroma potential therapy development preclinical models progression progression-free survival radiotherapy receptor tyrosine kinase RELA stereotactic radiosurgery subependymoma T cells T lymphocytes targeted therapy temozolomide tumor microenvironment tumor mutation burden tumor suppressor tyrosine kinase inhibitors U87MG vestibular schwannoma Warburg effect whole-brain radiation therapy YAP1 ZFTA |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9911053032003321 |
| MDPI - Multidisciplinary Digital Publishing Institute, 2023 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||